İçeriğe geç
akaturk Akademik ölçüm
Giriş Kayıt

Akademisyen

ABDULMELİK AYTATLI

ARAŞTIRMA GÖREVLİSİ

ERZURUM TEKNİK ÜNİVERSİTESİ FEN FAKÜLTESİ MOLEKÜLER BİYOLOJİ VE GENETİK BÖLÜMÜ

  • Ana Dal Fen Bilimleri ve Matematik Temel Alanı
  • Yan Dal Moleküler Biyoloji ve Genetik

Kayıtlı çıktılara kısa bakış — ayrıntılar aşağıda.

  • Makale 22
  • Proje 0
  • Kitap 2
  • Bildiri 1
  • Patent 0
  • Sanatsal 0
Scopus (SJR) Q1 9 Q2 7 Q3 1 Q4 3
WoS (JCR) Q1 7 Q2 4 Q3 5 Q4 3
TR Index 3 makale

Alan+yıl+tür normalize OpenAlex yüzdelik — Clarivate ESI / SciVal değildir.

Üst %1 makale 0
Üst %10 makale 2
Ort. yüzdelik 58.3%
Üst %1 payı 0.0%
Üst %10 payı 9.1%

Makaleler

YÖKSİS ve OpenAlex kaynak ayrımıyla makaleler; quartile ve TR Index ile daraltabilirsiniz.

Dizin filtreleri

Toplam 22 yayın

Scopus (SJR)
Q1 9 Q2 7 Q3 1 Q4 3
WoS (JCR)
Q1 7 Q2 4 Q3 5 Q4 3
TR Index
3 makale

Makale listesi

  1. 2025 Synthesis and Computational Evaluation of N-Acetyl-Derived Schiff Bases Incorporating 1,2,4-Triazoles for Dual Inhibition of Prostate Cancer Cells and Carbonic Anhydrases ACS Omega DOI 10.1021/acsomega.5c03271 YÖKSİS SJR Q1 JCR Q2 OpenAlex üst %10 OpenAlex 96.9%
  2. 2025 Curcumin as an Epigenetic Modulator: Suppression of Breast Cancer via the Hsa_circ_0001946/MiR-7-5p/Target Gene Axis Medicina DOI 10.3390/medicina61091600 YÖKSİS SJR Q2 JCR Q1 OpenAlex 13.0%
  3. 2025 CDR1as/miR-7-5p/IGF1R axis contributes to the suppression of cell viability in prostate cancer Turkish Journal of Biochemistry DOI 10.1515/tjb-2024-0122 YÖKSİS TR Index SJR Q3 JCR Q4 OpenAlex 56.8%
  4. 2024 Bioinformatics approach combined with experimental verification reveals OAS3 gene implicated in paclitaxel resistance in head and neck cancer HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK DOI 10.1002/hed.27803 YÖKSİS SJR Q1 JCR Q1 OpenAlex 85.5%
  5. 2024 In silico identification of differentially expressed microRNAs in thyroid cancer Human Gene DOI 10.1016/j.humgen.2024.201306 YÖKSİS SJR Q4 JCR Q4 OpenAlex 55.2%
  6. 2023 Design, synthesis, and biological evaluation of indole-modified tamoxifen relatives as potent anticancer agents RSC Medicinal Chemistry DOI 10.1039/d3md00157a YÖKSİS SJR Q1 JCR Q2 OpenAlex 89.0%
  7. 2022 AZD4547 targets the FGFR/Akt/SOX2 axis to overcome paclitaxel resistance in head and neck cancer. Cellular oncology (Dordrecht) DOI 10.1007/s13402-021-00645-6 YÖKSİS SJR Q1 JCR Q1 OpenAlex 77.2%
  8. 2021 MicroRNA-145 transcriptionally regulates Semaphorin 3A expression in prostate cancer cells Cell Biology International DOI 10.1002/cbin.11554 YÖKSİS SJR Q2 JCR Q3 OpenAlex 62.7%
  9. 2020 The AKT antagonist AZD5363 suppresses features associated with cancer progression in human larynx cancer cells The European Research Journal DOI 10.18621/eurj.624088 YÖKSİS TR Index OpenAlex 1.6%
  10. 2019 ING5 inhibits cancer aggressiveness by inhibiting Akt and activating p53 in prostate cancer CELL BIOLOGY INTERNATIONAL DOI doi: 10.1002/cbin.11227 YÖKSİS SJR Q2 JCR Q3 OpenAlex 70.1%
  11. 2019 Mode of action of carboplatin via activating p53/miR\u2010145 axis in head and neck cancers The Laryngoscope DOI 10.1002/lary.28492 YÖKSİS SJR Q1 JCR Q1 OpenAlex 81.7%
  12. 2018 CURRENT CANCER STEM CELL BIOMARKERS IN TONGUE SQUAMOUS CELL CARCINOMA Trakya University Journal of Natural Sciences DOI 10.23902/trkjnat.368829 YÖKSİS SJR Q4 OpenAlex 3.7%
  13. 2026 Combination of hsa-miR-21-3p/ sTNF-RI/ IL12-p40 /CCL25 serves as a promising panel of diagnostic biomarkers for distinguishing malignant from benign nodules in papillary thyroid cancer Endocrine DOI 10.1007/s12020-026-04612-9 YÖKSİS SJR Q2 JCR Q3 OpenAlex 36.7%
  14. 2025 Synthesis and Computational Evaluation of N-Acetyl-Derived Schiff Bases Incorporating 1,2,4-Triazoles for Dual Inhibition of Prostate Cancer Cells and Carbonic Anhydrases ACS Omega DOI 10.1021/acsomega.5c03271 YÖKSİS SJR Q1 JCR Q2 OpenAlex üst %10 OpenAlex 96.8%
  15. 2025 Curcumin as an Epigenetic Modulator: Suppression of Breast Cancer via the Hsa_circ_0001946/MiR-7-5p/Target Gene Axis Medicina DOI 10.3390/medicina61091600 YÖKSİS SJR Q2 JCR Q1 OpenAlex 13.0%
  16. 2024 Bioinformatics approach combined with experimental verification reveals OAS3 gene implicated in paclitaxel resistance in head and neck cancer Head & Neck DOI 10.1002/hed.27803 YÖKSİS SJR Q1 JCR Q1 OpenAlex 85.5%
  17. 2024 In silico identification of differentially expressed microRNAs in thyroid cancer Human Gene DOI 10.1016/j.humgen.2024.201306 YÖKSİS SJR Q4 JCR Q4 OpenAlex 55.2%
  18. 2023 Design, synthesis, and biological evaluation of indole-modified tamoxifen relatives as potent anticancer agents Royal Society of Chemistry (RSC) DOI 10.1039/D3MD00157A YÖKSİS SJR Q1 JCR Q2 OpenAlex 89.5%
  19. 2021 MicroRNA-145 transcriptionally regulates Semaphorin 3A expression in prostate cancer cells Cell Biology International DOI 10.1002/cbin.11554 YÖKSİS SJR Q2 JCR Q3 OpenAlex 62.7%
  20. 2021 AZD4547 targets the FGFR/Akt/SOX2 axis to overcome paclitaxel resistance in head and neck cancer Cellular Oncology DOI 10.1007/s13402-021-00645-6 YÖKSİS SJR Q1 JCR Q1 OpenAlex 77.2%

Akademisyenlere dön